---
schema_version: "secwatch.filing_event.v1"
accession: "0000875045-25-000040"
form_type: "8-K"
ticker: "BIIB"
cik: "0000875045"
company_name: "BIOGEN INC."
filed_at: "2025-10-14T23:59:59+00:00"
generated_at: "2026-05-17T04:02:17.752505+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Biogen expects ~$2M pre-tax IPR&D charge for Q3, impact of ($0.01)/share

## Summary
- Preliminary estimate: acquired IPR&D, upfront & milestone expense of ~$2M pre-tax.
- Estimated impact of ($0.01) per diluted share on both GAAP and non-GAAP EPS.
- Q3 2025 results not yet finalized; subject to closing procedures and could differ.

## SEC filing metadata
- accession: 0000875045-25-000040
- form_type: 8-K
- ticker: BIIB
- cik: 0000875045
- company_name: BIOGEN INC.
- filed_at: 2025-10-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/875045/000087504525000040/0000875045-25-000040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/875045/000087504525000040/biib-20251014.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000875045-25-000040
- JSON: https://secwatch.observer/filing/0000875045-25-000040.json
- Plain text: https://secwatch.observer/filing/0000875045-25-000040.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.